RHHBY and CHGCY Related Headlines
Go Back- Roche gets FDA clearance for two new laboratory analytical units
- Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets
- /C O R R E C T I O N -- Roche/
- Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
- Roche gets CE mark for blood test detecting Alzheimer's gene variant
- Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
- Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
- Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025
- Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
- Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
- Roche gets CE mark for glucose monitor and mySugr app integration
- Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
- Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
- Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV
- Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
- Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
RHHBY and CHGCY Related Press Releases
Go Back- Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets
- /C O R R E C T I O N -- Roche/
- Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
- Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
- New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
- Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
- Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025
- Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
- Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
- Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
- Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
- Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV
- Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
- Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
